Pfizer CEO Albert Bourla reached a drug pricing deal with the White House that includes more domestic drug production and a tariff exemption. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
